LEVERONE JASON A. (Chief Financial Officer) sold 2.3% of their position (303.00 shares) of ONKURE THERAPEUTICS, INC. on the open market
Open‑market sale worth $722.41 — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/25/2025ACC: 0001415889-25-018234
Officer· Chief Financial Officer
Since Oct 2024
-303.00
Net shares
Net seller
$722.41
Total sold
1
Open market trades
0B · 1S
1
Total transactions
303.00 disposed
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
−303.00
Price / share
$2.38
Trade value
$722.41
% of position
2.3%
6/23/2025
13.21K→12.91K
Total
Net shares
−303.00
Net value
-$722.41
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 6/23/2025 | S · Sale | −303.00 | $2.38 | $722.41 | 2.3% | 13.21K | 12.91K |
| Total | −303.00 | -$722.41 | ||||||
Derivative Transactions0
No derivative transactions reported